Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma

Author:

van Lieshout LauraORCID,van der Ploeg PhyllisORCID,Wesseling-Rozendaal YvonneORCID,van de Stolpe AnjaORCID,Bosch Steven,Lentjes-Beer Marjolein,Ottenheijm Meggy,Meriaan Annelen,Vos Caroline,de Hullu Joanne,Massuger Leon,Bekkers RuudORCID,Piek JurgenORCID

Abstract

High-grade serous ovarian carcinoma (HGSC), the most common subtype of ovarian cancer, has a high mortality rate. Although there are some factors associated with survival, such as stage of disease, there are remarkable differences in survival among women diagnosed with advanced stage disease. In this study, we investigate possible relations between survival and signal transduction pathway (STP) activity. We assessed the functional activity of the androgen receptor (AR), estrogen receptor (ER), phosphoinositide-3-kinase (PI3K), Hedgehog (HH), transforming growth factor beta (TGF-β) and canonical wingless-type MMTV integration site (Wnt) pathway in 85 primary tumor samples of patients with FIGO stage IIIC to IVB HGSC and disease-free survival (DFS) below 12 (n = 52) or over 24 months (n = 33). There were no significant differences in median pathway activity between patients with a short and long DFS. In univariate Cox proportional hazards analysis, ER pathway activity was related to a favorable DFS and overall survival (OS) in postmenopausal women (p = 0.033 and p = 0.041, respectively), but not in premenopausal women. We divided the postmenopausal group into subgroups based on ER pathway activity quartiles. Survival analysis revealed that postmenopausal women in the lowest ER quartile had a shorter DFS and OS (log-rank p = 0.006 and p < 0.001, respectively). Furthermore, we were able to form subgroups of patients based on an inverse relation between ER and PI3K pathway activity. In conclusion, in postmenopausal patients with advanced stage HGSC, a poorer survival outcome was associated with low functional ER pathway activity.

Funder

Ruby and Rose Foundation

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cancer statistics, 2020

2. Ovarian cancer statistics, 2018

3. Pathology of cancers of the female genital tract including molecular pathology

4. IKNL NKR Cijfers https://www.iknl.nl/nkr-cijfers?fs%7Cepidemiologie_id=7&fs%7Ctumor_id=305&fs%7Coverlevingssoort_id=75&fs%7Cperiode_van_diagnose_id=113%2C114%2C115%2C116%2C117%2C118&fs%7Cjaren_na_diagnose_id=16%2C17%2C18%2C19%2C20%2C21%2C22%2C23%2C24%2C25%2C26%2C27&cs%7Ct

5. Characteristics of 10-year survivors of high-grade serous ovarian carcinoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3